Controlled-release dopamine polymers as a novel approach to the treatment of Parkinson's disease.
Sabel
B A
BA
Institute of Medical Psychology, University of Munich Medical School, West Germany.
Freese
A
A
During
M J
MJ
D000818:Animals; D001921:Brain / Q000187:drug effects*; D003692:Delayed-Action Preparations; D004298:Dopamine / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D010300:Parkinson Disease / Q000188:drug therapy*; D011108:Polymers; D051381:Rats; D011919:Rats, Inbred Strains
D003692:Delayed-Action Preparations; D011108:Polymers; D004298:Dopamine